In this imaging-pharmacogenetics study, we aimed to assess the impact of ABCB1 genotype on SERT occupancy by citalopram as a proxy of intracerebral drug availability in a large sample of healthy controls and patients diagnosed with MDD using gold standard SERT quantification procedures. Here, SLC6A4 is linked to major depressive disorder.